SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001005477-06-000947
Filing Date
2006-02-14
Accepted
2006-02-14 15:22:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NUMBER 2 TO SCHEDULE 13G file001.txt SC 13G/A 11661
  Complete submission text file 0001005477-06-000947.txt   13613
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Subject) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48083 | Film No.: 06613975
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 605 THIRD AVE NEW YORK NY 10158
Business Address 605 THIRD AVE NEW YORK NY 10158 2124764654
NEUBERGER BERMAN INC (Filed by) CIK: 0001068144 (see all company filings)

IRS No.: 061523639 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice